Studies presented at the American Urilogical Association expand the role of the NMP22 Bladder Chek Test. It improves bladder cancer detection to 99 percent, aiding the earlier detection of cancer and is reported to indicate the likelihood of life threatening bladder malignancy. It is recommended for use in screening high risk populations for bladder cancer to save lives and reduce expense. It is also four times more effective than the conventional laboratory urine test in detecting recurrent bladder cancer.
Note: The contents of this blog are for informational purposes only and should not be construed as medical advice or substitute for professional care. For medical emergencies, dial 911!
Posts with tag NMP22 Bladder Chek Test
Fighting bladder cancer by finding it early
Continue reading Fighting bladder cancer by finding it early
